NLRP3 and endothelial dysfunction: Recently, several studies have shown that TMAO exacerbates cardiac fibrosis, vascular calcification, and endothelial dysfunction by activating the NLRP3 inflammasome (Boini et al., 2017; Li X. et al., 2019; Zhang et al., 2020).